GBA Group Pharma: GBA Group Pharma updates on clinical trial risks following Brexit

Written by Petra Hegmann on 28th July 2020. Posted in Client News.

[image_slider_no_space on_click=”prettyphoto” height=”600″ navigation_style=”light” images=”940,950,954,952,953,951″]